BIRD Form 144: Insider Sale of 2,188 Shares after Restricted Stock Lapse
Rhea-AI Filing Summary
Allbirds, Inc. (BIRD) Form 144 shows a proposed sale of 2,188 shares of common stock through Charles Schwab & Co., Inc. on 09/03/2025 with an aggregate market value of $13,928.00 and a total outstanding share count listed as 5,604,113. The securities were acquired as an equity compensation event described as a restricted stock lapse on 09/03/2025. The filer previously sold 2,146 shares on 06/03/2025 for gross proceeds of $15,273.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Compliance with Rule 144 disclosure is evident: broker, sale date, acquisition type, and prior sales are disclosed.
- Securities were acquired via equity compensation and are being sold after a restricted stock lapse, indicating planned liquidity from vested awards.
Negative
- Limited contextual information such as filer identity details (CIK/CCC) are not provided in the content.
- Aggregate market value and proceeds are small, which could reflect minimal liquidity needs but provide no insight into broader insider sentiment.
Insights
TL;DR: Insider intends a small sale of vested restricted shares, indicating routine liquidity rather than a corporate event.
The filing documents a proposed sale of 2,188 shares via a retail broker with a market value of $13,928, following a prior sale of 2,146 shares for $15,273. The shares were acquired through equity compensation (restricted stock lapse) on the same date as the proposed sale. From a market-impact perspective, the transaction size is immaterial relative to typical public float levels, and the filing contains the standard attestation regarding material undisclosed information. No new corporate actions, litigation, or financial results are disclosed.
TL;DR: This is a routine Rule 144 notice documenting disposition of vested shares with standard seller attestation.
The form records the mechanics required under Rule 144 for an individual selling restricted shares after lapse of restrictions. It identifies the broker, sale date, and acquisition as equity compensation. The prior sale within three months is disclosed, meeting aggregation requirements. There is no indication of governance changes, insider role changes, or transactional terms beyond standard equity compensation treatment. The filing fulfills disclosure protocol without signaling governance concerns.